Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions - a Prospective Study

NCT07272187 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT07272187
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07272187 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic Ultrasound-guided Radiofrequency Ablation for Upper Gastrointestinal Tract Lesions - a Prospective Study
Lead sponsor
Herlev Hospital
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
December 31, 2041
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conn syndrome, endoscopic ultrasound (eus), insulinoma; pancreas, men1, nets, radiofrequency ablation